Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer.
View/ Open
Date
2017-06ICR Author
Author
Lote, H
Spiteri, I
Ermini, L
Vatsiou, A
Roy, A
McDonald, A
Maka, N
Balsitis, M
Bose, N
Simbolo, M
Mafficini, A
Lampis, A
Hahne, JC
Trevisani, F
Eltahir, Z
Mentrasti, G
Findlay, C
Kalkman, EAJ
Punta, M
Werner, B
Lise, S
Aktipis, A
Maley, C
Greaves, M
Braconi, C
White, J
Fassan, M
Scarpa, A
Sottoriva, A
Valeri, N
Type
Journal Article
Metadata
Show full item recordAbstract
Background Patients often ask oncologists how long a cancer has been present before causing symptoms or spreading to other organs. The evolutionary trajectory of cancers can be defined using phylogenetic approaches but lack of chronological references makes dating the exact onset of tumours very challenging.Patients and methods Here, we describe the case of a colorectal cancer (CRC) patient presenting with synchronous lung metastasis and metachronous thyroid, chest wall and urinary tract metastases over the course of 5 years. The chest wall metastasis was caused by needle tract seeding, implying a known time of onset. Using whole genome sequencing data from primary and metastatic sites we inferred the complete chronology of the cancer by exploiting the time of needle tract seeding as an in vivo 'stopwatch'. This approach allowed us to follow the progression of the disease back in time, dating each ancestral node of the phylogenetic tree in the past history of the tumour. We used a Bayesian phylogenomic approach, which accounts for possible dynamic changes in mutational rate, to reconstruct the phylogenetic tree and effectively 'carbon date' the malignant progression.Results The primary colon cancer emerged between 5 and 8 years before the clinical diagnosis. The primary tumour metastasized to the lung and the thyroid within a year from its onset. The thyroid lesion presented as a tumour-to-tumour deposit within a benign Hurthle adenoma. Despite rapid metastatic progression from the primary tumour, the patient showed an indolent disease course. Primary cancer and metastases were microsatellite stable and displayed low chromosomal instability. Neo-antigen analysis suggested minimal immunogenicity.Conclusion Our data provide the first in vivo experimental evidence documenting the timing of metastatic progression in CRC and suggest that genomic instability might be more important than the metastatic potential of the primary cancer in dictating CRC fate.
Collections
Subject
Humans
Colorectal Neoplasms
Neoplasm Metastasis
Disease Progression
Genome
Research team
Signal Transduction & Molecular Pharmacology
Biology of Childhood Leukaemia
Evolutionary Genomics & Modelling
Gastrointestinal Cancer Biology and Genomics
Language
eng
Date accepted
2017-03-01
License start date
2017-06
Citation
Annals of oncology : official journal of the European Society for Medical Oncology, 2017, 28 (6), pp. 1243 - 1249